Searched for
YK SAPRU
Glivec case: Cancer Patients’ Aid Association, NGO that fought Novartis favoured by ad agenciesAn old friend of the advertising industry has been all over the news this week: CPAA, an NGO that fought the Novartis patent case in the Su...- Ex-J&J India head led fight against patentCancer Patients Aid Association is ironically headed by a former country head of a multi-national medical products company.
- Prices of patented medicines may come down by a third if panel's recommendation acceptedAn inter-ministerial group tasked with regulating prices of patented medicines has recommended using a per capita income-linked reference p...
- Natco Pharma files India's first compulsory licence pleaNatco Pharma has applied for the country's first compulsory licence to sell a generic version of Bayer's patented medicine.
- Cipla in talks with Centre to share cancer drug know-howPharma powerhouse Cipla has started talks with the government to share knowledge on making cancer drugs, which, if successful, could radica...
- Cipla makes cancer drug cheaperCipla has launched a copycat version of German pharma company Bayer’s cancer medicine Nexavar at one-tenth the price.
- HC rejects Bayer plea on Nexavar copycatThe Delhi HC dismissed an appeal by German drugmaker Bayer that sought to stop Cipla from obtaining a marketing approval from the country’s...
- Maharashtra wants to keep tabs on healthcare servicesMaharashtra may set its foot where almost no state government has ventured so far and where even the Centre fears to tread.
- Of patents and pre-grant oppositionsOn January 25 this year, the patent office in Chennai rejected a patent application by pharma MNC Novartis for its anti-cancer drug Glivec ...
Load More- Natco Pharma files India's first compulsory licence plea
